- Home
- KMDA vs RPAY Comparison
KMDA vs RPAY Comparison
Compare KMDA & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- RPAY
- Stock Information
- Founded
- KMDA 1990
- RPAY 2006
- Country
- KMDA Israel
- RPAY United States
- Employees
- KMDA N/A
- RPAY N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- KMDA Health Care
- RPAY Consumer Discretionary
- Exchange
- KMDA Nasdaq
- RPAY Nasdaq
- Market Cap
- KMDA 398.5M
- RPAY 364.0M
- IPO Year
- KMDA N/A
- RPAY N/A
- Fundamental
- Price
- KMDA $6.62
- RPAY $3.79
- Analyst Decision
- KMDA Strong Buy
- RPAY Buy
- Analyst Count
- KMDA 2
- RPAY 9
- Target Price
- KMDA $13.00
- RPAY $7.22
- AVG Volume (30 Days)
- KMDA 70.7K
- RPAY 1.4M
- Earning Date
- KMDA 11-10-2025
- RPAY 11-10-2025
- Dividend Yield
- KMDA 3.00%
- RPAY N/A
- EPS Growth
- KMDA 27.97
- RPAY N/A
- EPS
- KMDA 0.32
- RPAY N/A
- Revenue
- KMDA $169,517,000.00
- RPAY $310,367,000.00
- Revenue This Year
- KMDA $14.49
- RPAY $0.04
- Revenue Next Year
- KMDA $10.12
- RPAY $7.72
- P/E Ratio
- KMDA $20.13
- RPAY N/A
- Revenue Growth
- KMDA 9.67
- RPAY 1.45
- 52 Week Low
- KMDA $5.54
- RPAY $3.59
- 52 Week High
- KMDA $9.16
- RPAY $9.75
- Technical
- Relative Strength Index (RSI)
- KMDA 42.74
- RPAY 31.82
- Support Level
- KMDA $6.66
- RPAY $4.12
- Resistance Level
- KMDA $6.93
- RPAY $5.25
- Average True Range (ATR)
- KMDA 0.17
- RPAY 0.26
- MACD
- KMDA -0.02
- RPAY -0.07
- Stochastic Oscillator
- KMDA 10.71
- RPAY 4.33
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.